We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$277B
AUM Growth
+$17B
Cap. Flow
+$10.3B
Cap. Flow %
3.74%
Top 10 Hldgs %
13%
Holding
7,048
New
169
Increased
3,077
Reduced
2,915
Closed
401

Sector Composition

Rank Sector Weight
1 Healthcare 8.93%
2 Technology 8.69%
3 Financials 8.37%
4 Communication Services 6.94%
5 Consumer Staples 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXRX
5576
DELISTED
Concordia International Corp. Common Stock
CXRX
$30K ﹤0.01%
1,406
-75,639
-98% -$1.99M
KTEC
5577
DELISTED
Key Technology Inc
KTEC
$30K ﹤0.01%
3,300
+3,291
+36,567% +$28.5K
CRTN
5578
DELISTED
Cartesian, Inc.
CRTN
$30K ﹤0.01%
30,109
-13
-0% -$20
UBOH
5579
DELISTED
United Bancshares Inc/OH
UBOH
$30K ﹤0.01%
1,678
+166
+11% +$3.06K
JJN
5580
DELISTED
iPath Bloomberg Nickel Subindex Total Return ETN due October 22, 2037
JJN
$30K ﹤0.01%
2,663
CLRB icon
5581
Cellectar Biosciences
CLRB
$20.5M
$29K ﹤0.01%
+3
New +$25.1K
CYRX icon
5582
CryoPort
CYRX
$761M
$29K ﹤0.01%
14,211
+9,990
+237% +$20K
FISI icon
5583
Financial Institutions
FISI
$816M
$29K ﹤0.01%
1,093
+269
+33% +$7.42K
GURE
5584
Gulf Resources
GURE
$4.65M
$29K ﹤0.01%
378
-340
-47% -$26K
INSG icon
5585
Inseego
INSG
$114M
$29K ﹤0.01%
1,929
-596
-24% -$9.14K
NGVC icon
5586
Vitamin Cottage Natural Grocers
NGVC
$739M
$29K ﹤0.01%
2,236
+79
+4% +$1.17K
NLR icon
5587
VanEck Uranium + Nuclear Energy ETF
NLR
$3.82B
$29K ﹤0.01%
594
-16
-3% -$769
MBTF
5588
DELISTED
MBT Financial Corporation
MBTF
$29K ﹤0.01%
3,632
-42,858
-92% -$344K
PAF
5589
DELISTED
Invesco FTSE RAFI Asia Pacific ex-Japan ETF
PAF
$29K ﹤0.01%
660
+297
+82% +$13.2K
EWEM
5590
DELISTED
Invesco MSCI Emerging Markets Equal Country Weight ETF
EWEM
$29K ﹤0.01%
1,036
-493
-32% -$13.6K
UNXL
5591
DELISTED
Uni-Pixel, Inc.
UNXL
$29K ﹤0.01%
19,572
+2,099
+12% +$3.67K
BDCS
5592
DELISTED
UBS AG Exchange Traded Access Securities (E-TRACS)Linked to the Wells Fargo Business Development Com
BDCS
$29K ﹤0.01%
1,411
-780
-36% -$15.8K
PGLC
5593
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$29K ﹤0.01%
6,761
+6,723
+17,692% +$27.2K
ACNB icon
5594
ACNB Corp
ACNB
$656M
$28K ﹤0.01%
1,102
-2,058
-65% -$47.8K
DRV icon
5595
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.5M
$28K ﹤0.01%
48
LCTX icon
5596
Lineage Cell Therapeutics
LCTX
$269M
$28K ﹤0.01%
12,045
+7,290
+153% +$17.9K
MTR
5597
Mesa Royalty Trust
MTR
$5.4M
$28K ﹤0.01%
2,600
SMN icon
5598
ProShares UltraShort Materials
SMN
$4.17M
$28K ﹤0.01%
65
-91
-58% -$39.9K
IRG
5599
DELISTED
Ignite Restaurant Group, Inc.
IRG
$28K ﹤0.01%
17,760
+15,510
+689% +$40.2K
CYNA
5600
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$28K ﹤0.01%
1,700
+1,580
+1,317% +$21.3K

Similar funds

Morgan Stanley's Q2 2016 Portfolio in Review

As of Q2 2016, Morgan Stanley held 7,048 positions worth $277B, up 6.5% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Morgan Stanley deployed $10.3B of net new capital in Q2 2016, opening 169 new positions and adding to 3,077 existing holdings. Its largest new stake was S&P Global: 9,342,671 shares worth $1B.

By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.1% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $542M trimmed.

  • Morgan Stanley's largest Q2 2016 buy was S&P Global: 9,342,671 shares worth $1B.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $1.11B increase.
  • Morgan Stanley's biggest Q2 2016 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $542M.
  • Morgan Stanley fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $807M.
  • Morgan Stanley's ten largest holdings make up 13% of its $277B portfolio in Q2 2016.
  • Morgan Stanley opened 169 new positions and closed 401 in Q2 2016.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $277B.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.